FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897154493> ?p ?o ?g. }

• W2897154493 endingPage "42s" @default.
• W2897154493 startingPage "42s" @default.
• W2897154493 abstract "Purpose Kyrgyzstan and Tajikistan are Central Asian low-income countries. Breast cancer is the most common cancer in the Kyrgyz Republic and in Tajikistan. Almost 40% of breast cancer cases are detected in advanced stages. The Kyrgyzstan and Tajikistan health care systems do not guarantee equal access to treatment to all people, and patients with breast cancer have to pay out of pocket for the entire course of chemotherapy treatment. Therefore, evaluation of the cost of a chemotherapy regimen represents a first step in the policy discussion and the creation of a government copayment system that would guarantee access to chemotherapy and ensure the effective and sustainable basic-level treatment of most patients. Methods Resource and Policy Exchange, Tajik, and Kyrgyz experts calculated the average drug dose per patient for adriamycin and cyclophosphamide; cyclophosphamide, methotrexate, and fluorouracil; and fluorouracil, adriamycin, and cyclophosphamide regimens recommended by the Breast Health Global Initiative as basic-level therapy and the taxanes average dose—docetaxel and paclitaxel—as enhanced-level therapy. The drug procurement cost per cycle was calculated for each chemotherapy regimen on the basis of on an average dose per patient (standard 1.75 m 2 ), the average number of doses per cycle, and the average list price per milligram. Experts acquired cancer drug price lists from different pharmacies using the lowest generic prices available in Kyrgyzstan and Tajikistan. Results The cost of the basic chemotherapy regimen adriamycin and cyclophosphamide is $249 USD in Kyrgyzstan and $222 USD in Tajikistan. That of the cyclophosphamide, methotrexate, and fluorouracil regimen is $587 USD in Kyrgyzstan and $486 USD in Tajikistan. That of the fluorouracil, adriamycin, and cyclophosphamide regimen is $326 USD in Tajikistan and $526 USD in Kyrgyzstan. However, the cost of the taxanes regimen—enhanced level—is more expensive. The cost of a paclitaxel monotherapy regimen is $4896 USD in Kyrgyzstan and $4,695 USD in Tajikistan, and that of a docetaxel monotherapy regimen $1,411 USD in Kyrgyzstan and $1,086 USD in Tajikistan. Conclusion Chemotherapy regimen cost calculation is an integral part of advocacy and policy work. It helped to negotiate basic-level chemotherapy treatment insurance coverage for women with breast cancer. The cost of a monotherapy taxanes regimen is expensive and requires additional financial resources. AUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/jco/site/ifc . No COIs from the authors." @default.
• W2897154493 created "2018-10-26" @default.
• W2897154493 creator A5055100333 @default.
• W2897154493 creator A5057054528 @default.
• W2897154493 creator A5091018744 @default.
• W2897154493 date "2018-10-01" @default.
• W2897154493 modified "2023-09-26" @default.
• W2897154493 title "Chemotherapy Affordability on Basic and Enhanced Therapy Levels in Kyrgyzstan and Tajikistan" @default.
• W2897154493 doi "https://doi.org/10.1200/jgo.18.10490" @default.
• W2897154493 hasPublicationYear "2018" @default.
• W2897154493 type Work @default.
• W2897154493 sameAs 2897154493 @default.
• W2897154493 citedByCount "0" @default.
• W2897154493 crossrefType "journal-article" @default.
• W2897154493 hasAuthorship W2897154493A5055100333 @default.
• W2897154493 hasAuthorship W2897154493A5057054528 @default.
• W2897154493 hasAuthorship W2897154493A5091018744 @default.
• W2897154493 hasBestOaLocation W28971544931 @default.
• W2897154493 hasConcept C121608353 @default.
• W2897154493 hasConcept C126322002 @default.
• W2897154493 hasConcept C143998085 @default.
• W2897154493 hasConcept C160735492 @default.
• W2897154493 hasConcept C162324750 @default.
• W2897154493 hasConcept C2776694085 @default.
• W2897154493 hasConcept C2776755627 @default.
• W2897154493 hasConcept C2779848557 @default.
• W2897154493 hasConcept C2781190966 @default.
• W2897154493 hasConcept C2781413609 @default.
• W2897154493 hasConcept C2983635472 @default.
• W2897154493 hasConcept C50522688 @default.
• W2897154493 hasConcept C530470458 @default.
• W2897154493 hasConcept C71924100 @default.
• W2897154493 hasConceptScore W2897154493C121608353 @default.
• W2897154493 hasConceptScore W2897154493C126322002 @default.
• W2897154493 hasConceptScore W2897154493C143998085 @default.
• W2897154493 hasConceptScore W2897154493C160735492 @default.
• W2897154493 hasConceptScore W2897154493C162324750 @default.
• W2897154493 hasConceptScore W2897154493C2776694085 @default.
• W2897154493 hasConceptScore W2897154493C2776755627 @default.
• W2897154493 hasConceptScore W2897154493C2779848557 @default.
• W2897154493 hasConceptScore W2897154493C2781190966 @default.
• W2897154493 hasConceptScore W2897154493C2781413609 @default.
• W2897154493 hasConceptScore W2897154493C2983635472 @default.
• W2897154493 hasConceptScore W2897154493C50522688 @default.
• W2897154493 hasConceptScore W2897154493C530470458 @default.
• W2897154493 hasConceptScore W2897154493C71924100 @default.
• W2897154493 hasIssue "Supplement 3" @default.
• W2897154493 hasLocation W28971544931 @default.
• W2897154493 hasOpenAccess W2897154493 @default.
• W2897154493 hasPrimaryLocation W28971544931 @default.
• W2897154493 hasRelatedWork W2031329688 @default.
• W2897154493 hasRelatedWork W2080820783 @default.
• W2897154493 hasRelatedWork W2160841316 @default.
• W2897154493 hasRelatedWork W2388730008 @default.
• W2897154493 hasRelatedWork W2620183848 @default.
• W2897154493 hasRelatedWork W2945263175 @default.
• W2897154493 hasRelatedWork W3031289629 @default.
• W2897154493 hasRelatedWork W3032029751 @default.
• W2897154493 hasRelatedWork W4214554217 @default.
• W2897154493 hasRelatedWork W4229993127 @default.
• W2897154493 hasVolume "4" @default.
• W2897154493 isParatext "false" @default.
• W2897154493 isRetracted "false" @default.
• W2897154493 magId "2897154493" @default.
• W2897154493 workType "article" @default.